Clinical Infectious Diseases · 2023 · 60 citations · 29 references
MedicineInfectious DiseasesClinical EpidemiologyEpidemiologyImmunizationAdverse Events Following ImmunizationCardiovascular DiseaseCardiovascular EpidemiologyCardiovascular RiskThrombosisVaccinationCardiovascular ImpactsCohort Study InvestigationLong-term Cardiovascular Follow-upLong-term Cardiovascular SequelaeSars-cov-2 InfectionSevere Acute Respiratory Syndrome
BACKGROUND: Growing evidence suggests that some coronavirus disease 2019 (COVID-19) survivors experience a wide range of long-term postacute sequelae. We examined the postacute risk and burden of new-incident cardiovascular, cerebrovascular, and other thrombotic complications after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a highly vaccinated multiethnic Southeast Asian population, during Delta predominance. METHODS: This cohort study used national testing and healthcare claims databases in Singapore to build a cohort of individuals who had a positive SARS-CoV-2 test between 1 September and 30 November 2021 when Delta predominated community transmission. Concurrently, we constructed a test-negative control group by enrolling individuals between 13 April 2020 and 31 December 2022 with no evidence of SARS-CoV-2 infection. Participants in both groups were followed up for a median of 300 days. We estimated risks of new-incident cardiovascular, cerebrovascular, and other thrombotic complications using doubly robust competing-risks survival analysis. Risks were reported using 2 measures: hazard ratio (HR) and excess burden (EB) with 95% confidence intervals. RESULTS: We included 106 012 infected cases and 1 684 085 test-negative controls. Compared with the control group, individuals with COVID-19 exhibited increased risk (HR, 1.157 [1.069-1.252]) and excess burden (EB, 0.70 [.53-.88]) of new-incident cardiovascular and cerebrovascular complications. Risks decreased in a graded fashion for fully vaccinated (HR, 1.11 [1.02-1.22]) and boosted (HR, 1.10 [.92-1.32]) individuals. Conversely, risks and burdens of subsequent cardiovascular/cerebrovascular complications increased for hospitalized and severe COVID-19 cases (compared to nonhospitalized cases). CONCLUSIONS: Increased risks and excess burdens of new-incident cardiovascular/cerebrovascular complications were reported among infected individuals; risks can be attenuated with vaccination and boosting.
29
Long-term cardiovascular outcomes of COVID-19
Yan Xie, Evan Xu, Benjamin Bowe et al. · Nature Medicine · 2022 · 2.1K citations · Full text
High-dimensional characterization of post-acute sequelae of COVID-19
Ziyad Al‐Aly, Yan Xie, Benjamin Bowe · Nature · 2021 · 1.6K citations · Full text
The COVID-19 Pandemic and the $16 Trillion Virus
David Cutler, Lawrence H. Summers · JAMA · 2020 · 842 citations · Full text
Public Health, Infectious Disease Control, Infectious Diseases +9